Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biofrontera Inc
(NQ:
BFRI
)
0.8400
+0.0890 (+11.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biofrontera Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Is Biolase (BIOL) Stock Down 13% Today?
May 12, 2023
Biolase (BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023.
Via
InvestorPlace
Why Is Assure (IONM) Stock Down 36% Today?
May 12, 2023
Assure (IONM) stock is falling on Friday after the medical company released preliminary earnings for the first quarter of 2023.
Via
InvestorPlace
Why Is Getaround (GETR) Stock Up 104% Today?
May 12, 2023
Getaround (GETR) stock is getting a boost on Friday after the company announced its intention to acquire HyreCar (HYRE).
Via
InvestorPlace
Earnings Scheduled For May 12, 2023
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
Biofrontera: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
May 12, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Resignation of CEO
May 12, 2023
Via
ACCESSWIRE
Biofrontera Earnings Preview
May 11, 2023
Via
Benzinga
BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates
May 12, 2023
BFRI stock earnings show Biofrontera missing analyst estimates for earnings per share and revenue for the first quarter.
Via
InvestorPlace
Biofrontera Inc. Announces New Secured Line of Credit up to $6.5 Million
May 11, 2023
Via
ACCESSWIRE
Biofrontera Collaborates with The Skin Cancer Foundation to Raise Awareness of Skin Cancer Prevention
May 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Report First Quarter 2023 Financial Results on May 12, 2023
April 28, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R)
April 26, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting
March 17, 2023
Via
ACCESSWIRE
Biofrontera's Earnings Outlook
March 07, 2023
Via
Benzinga
Biofrontera's Return On Capital Employed Overview
December 26, 2022
Via
Benzinga
Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce
March 27, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 17, 2023
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!
Via
InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
March 17, 2023
Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.
Via
Benzinga
CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
March 09, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 08, 2023
Via
Benzinga
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
March 08, 2023
Via
ACCESSWIRE
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023
March 02, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
February 24, 2023
Via
Benzinga
Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
February 22, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 12, 2023
Via
Benzinga
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
January 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022
January 09, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.